Literature DB >> 10670860

Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy.

R S Henry-Tillman1, S E Harms, K C Westbrook, S Korourian, V S Klimberg.   

Abstract

BACKGROUND: Occult primary breast cancer (OPBC) represents less than 1% of breast cancer. In only a third of cases, mammography identifies a primary tumor. We hypothesized that rotating delivery of excitation off-resonance breast magnetic resonance imaging (MRI) would identify or exclude the breast as a primary site in patients with OPBC.
METHODS: In a retrospective review, 10 patients were identified with OPBC in which MRI was performed. Malignant appearing lesions were correlated with histopathologic findings at biopsy or surgery.
RESULTS: MRI identified the primary site in 8 of 10 cases as breast (80%), and excluded it in 2 cases. The extent of disease and location was accurately predicted when compared with histopathologic specimen.
CONCLUSIONS: As we continue to focus on a cure of early breast cancer, it is imperative that diagnostic images become more sensitive and specific. MRI accurately predicted OPBC in this subset of patients.

Entities:  

Mesh:

Year:  1999        PMID: 10670860     DOI: 10.1016/s0002-9610(99)00221-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

Review 1.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

2.  Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium.

Authors:  Wendy B DeMartini; Laura Ichikawa; Bonnie C Yankaskas; Diana Buist; Karla Kerlikowske; Berta Geller; Tracy Onega; Robert D Rosenberg; Constance D Lehman
Journal:  J Am Coll Radiol       Date:  2010-11       Impact factor: 5.532

Review 3.  Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines.

Authors:  M B Taylor; N R Bromham; S E Arnold
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

4.  Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.

Authors:  Wendy B Demartini; Brenda F Kurland; Robert L Gutierrez; C Craig Blackmore; Sue Peacock; Constance D Lehman
Journal:  Eur Radiol       Date:  2011-02-27       Impact factor: 5.315

5.  Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.

Authors:  C Walter; K Scheidhauer; A Scharl; U-J Goering; P Theissen; H Kugel; T Krahe; U Pietrzyk
Journal:  Eur Radiol       Date:  2003-01-23       Impact factor: 5.315

Review 6.  FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.

Authors:  K Scheidhauer; C Walter; M D Seemann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-06       Impact factor: 9.236

7.  Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial.

Authors:  Wendy B DeMartini; Lucy Hanna; Constantine Gatsonis; Mary C Mahoney; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2012-09       Impact factor: 3.959

8.  Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy.

Authors:  Katrien Schelfout; E Kersschot; M Van Goethem; L Thienpont; J Van den Haute; A Roelstraete; A De Schepper
Journal:  Eur Radiol       Date:  2002-11-19       Impact factor: 5.315

9.  Retrospective study of women presenting with axillary metastases from occult breast carcinoma.

Authors:  D Kay Blanchard; David R Farley
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

10.  Diffusion weighted MRI by spatiotemporal encoding: analytical description and in vivo validations.

Authors:  Eddy Solomon; Noam Shemesh; Lucio Frydman
Journal:  J Magn Reson       Date:  2013-03-14       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.